Journey Medical Corp

DERM

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001867066

SEC filings (opens in a new tab)

No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Journey Medical Corp changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of DERM: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	21	36	+15
Shares	2.14M	1.36M	−776.7K (−36.4%)
Value	$5.85M	$7.80M	+$1.95M (+33.4%)

New holders (19)

Institutions that held Journey Medical Corp at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to DERM in Q4 2023
Institution	Shares	Value	% of portfolio
EAM Investors, LLC	110,509	$636.5K	0.11%
Acadian Asset Management LLC	28,274	$162.0K	0.00%
Jane Street Group, LLC	27,749	$159.8K	0.00%
Virtu Financial LLC	26,586	$153.0K	0.01%
Cubist Systematic Strategies, LLC	23,438	$135.0K	0.00%
XTX Topco Ltd	22,737	$131.0K	0.03%
Walleye Capital LLC	22,200	$127.9K	0.00%
Man Group plc	18,268	$105.2K	0.00%
Independent Financial Group, LLC	17,202	$99.1K	0.01%
Northern Trust Corp	16,654	$95.9K	0.00%
Citadel Advisors LLC	11,357	$65.4K	0.00%
Advisor Group Holdings, Inc.	5,455	$31.4K	0.00%
Tucker Asset Management LLC	2,600	$15.0K	0.00%
Federated Hermes, Inc.	833	$4.80K	0.00%
Lazard Asset Management LLC	351	$2.00K	0.00%
Morgan Stanley	200	$1.15K	0.00%
Bank of America Corp	172	$991	0.00%
FMR LLC	128	$734	0.00%
RIA Advisory Group LLC	1,767	–	–

Sold out (4)

Institutions that held Journey Medical Corp at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of DERM in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Tang Capital Management LLC	576,100	$1.58M
B. Riley Financial, Inc.	429,595	$1.18M
Nantahala Capital Management, LLC	348,663	$955.3K
Tower Research Capital LLC (TRC)	1,730	$4.74K